from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2586c/secF

LFCtreatmentdescriptionclass of inhibitor

-2.002

Amikacinug/mL Amikacintranslation

-1.884

Cap5-10ug/mL Capreomycintranslation

-2.383

Rox10-50 ug/mL Roxithromycintranslation

-0.432

SM2-5 ug/mL Streptomycintranslation

-2.258

Tet5-10 ug/mL Tetracyclinetranslation

-1.097

Rif0.2-5ug/mL Rifampicintranscription

-0.974

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.131

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.512

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.611

CPZ10-50 ug/mL Chlorpromazinerespiration

1.459

Clofazimine10-13 ug/mL Clofaziminerespiration

0.907

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.105

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.572

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.115

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.912

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.187

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.767

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.647

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.429

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.063

KCN5-20 ug/mL Potassium cyaniderespiration

0.880

NaN30.2-2 mM Sodium aziderespiration

-0.150

Nigericin50 uM Nigericinrespiration

-1.032

TRC10-150 ug/mL Triclosanrespiration

-0.166

TRZ10-25 ug/mL Thioridazinerespiration

-1.017

Valinomycin0.5-10 uM Valinomycinrespiration

0.950

ZnSO42 mM ZnSO4respiration

0.747

menadione6-10 ug/mL Menadionerespiration

0.671

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.314

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.234

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.146

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.947

NRP_1Non-replicating persistence stage 1dosRassociated

0.604

Amp0.2mg/mL AmpicillincellWall

0.371

Cephalexin20-100 ug/mL CephalexincellWall

0.510

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.239

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.011

EMB10-20 ug/mL EthambutolcellWall

-0.199

Eta12-40 ug/mL EthionamidecellWall

0.343

INH0.2-0.4 ug/mL IsoniazidcellWall

0.546

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.540

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.463

BZA0.12 mg/mL BenzamidearomaticAmides

-0.419

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.308

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.310

H2O24 mM hydrogen peroxideDNAdamaging

-0.004

Levo10 ug/mL LevofloxacinDNAdamaging

-0.034

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.999

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.041

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.371

UVUV-irradiationDNAdamaging

-0.807

ARP41-4 ug/mL Antitubercular compound ARP4?

0.328

Antimycin12.5-50 ug/mL Antimycin A?

0.558

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.676

PA_110-50 ug/mL Antitubercular compound PA-1?

0.515

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.166

PA8240.2-2 ug/mL PA-824?

-0.292

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.095

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.712

Verapamil50 uM Verapamil?

0.323

mercaptoethanol2 mM 2-Mercaptoethanol?

0.478

methoxatin10-20 ug/mL Methoxatin?